Pharmacy Fall Conference - 2014

What's New in the Management of Heart Failure?

Activity Details
  • Credit Type: CPE
  • Credit Amount: 1.00
  • Cost: $5.00
  • Release: Feb 9, 2015
  • Expires: Oct 23, 2017
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Sara D.  Brouse Sara D. Brouse, PharmD, BCPS (AQ Cardiology), FCCP
Clinical Pharmacy Specialist, Cardiology
College of Pharmacy
University of Kentucky
Lexington, KY

Needs Statement

Heart failure is a rapidly evolving field and a disease process that is rapidly increasing in the population; new treatment guidelines have been published and its important for the pharmacist to maintain competency & stay abreast of novel therapies/literature to provide optimal patient outcomes.

Target Audience

Pharmacists

Objectives

Upon Completion of this activity Pharmacist will be able to:

1. Compare/contrast management of heart failure with and without preserved ejection fraction
2. Evaluate novel treatment options for managing heart failure in relation to standard therapies

Accreditation

CPE
ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-0000-15-019-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

Sara Brouse, PharmD (Speaker) has no relevant financial relationships with any commercial interests.

Sara Brouse does not intend to discuss the off-label use of a product.

No planners have any relevant financial relationships to disclose.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.